APRE - Aprea Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APRE is currently covered by 1 analysts with an average price target of $18.09. This is a potential upside of $14.95 (476.11%) from yesterday's end of day stock price of $3.14.

Aprea Therapeutics's activity chart (see below) currently has 13 price targets and 18 ratings on display. The stock rating distribution of APRE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 23.5 days.

Highest price target for APRE is $20, Lowest price target is $20, average price target is $18.09.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 17-Dec-2024. First documented stock forecast 28-Oct-2019.

Best performing analysts who are covering APRE - Aprea Therapeutics:

Jeffrey Hung Andrew Fein Gregory Renza Madhu Kumar Jessica Fye Joseph Pantginis

Currently out of the existing stock ratings of APRE, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$16.95 (555.74%)

$20

8 days ago
(17-Dec-2024)

0/10 (0%)

$16.66 (498.80%)

Hold

$80

$76.95 (2522.95%)

$160

2 years 9 months 9 days ago
(16-Mar-2022)

1/4 (25%)

$40.2 (101.01%)

44

Hold

$40

$36.95 (1211.48%)

$80

2 years 9 months 9 days ago
(16-Mar-2022)

3/4 (75%)

$0.2 (0.50%)

21

Sell

$500

3 years 4 months 6 days ago
(20-Aug-2021)

1/1 (100%)

$47.6 (10.52%)

2

Sell

$60

$55.85 (1345.78%)

$100

3 years 4 months 14 days ago
(12-Aug-2021)

3/3 (100%)

$-20.8 (-25.74%)

72

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APRE (Aprea Therapeutics) average time for price targets to be met?

On average it took 23.5 days on average for the stock forecasts to be realized with a an average price target met ratio 58.33

Which analyst has the current highest performing score on APRE (Aprea Therapeutics) with a proven track record?

JEFFREY HUNG

Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?

Jeffrey Hung works at MORGAN STANLEY and has 6 price targets and 3 ratings on APRE

Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?

Gregory Renza with highest potential upside - $76.95

Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?